---
document_datetime: 2023-09-21 19:57:24
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kymriah-epar-all-authorised-presentations_en.pdf
document_name: kymriah-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.648934
conversion_datetime: 2025-12-23 01:18:12.012884
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength                    | Pharmaceutical form     | Route of administration   | Immediate Packaging          | Content (concentration)           | Pack size      |
|------------------|-------------------|-----------------------------|-------------------------|---------------------------|------------------------------|-----------------------------------|----------------|
| EU/1/18/1297/001 | Kymriah           | 1.2 x 10 6 - 6 x 10 8 cells | Dispersion for infusion | Intravenous use           | Bag (ethylene vinyl acetate) | Patient specific up to 50 ml max. | 1 or more bags |